Latest "Tianyin Pharmaceutical" News Stories

00:22 EDT 22nd October 2017 | BioPortfolio

Here are the most relevant search results for "Tianyin Pharmaceutical" found in our extensive news archives from over 250 global news sources.

More Information about Tianyin Pharmaceutical on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Tianyin Pharmaceutical for you to read. Along with our medical data and news we also list Tianyin Pharmaceutical Clinical Trials, which are updated daily. BioPortfolio also has a large database of Tianyin Pharmaceutical Companies for you to search.

Showing "Tianyin Pharmaceutical" News Articles 1–25 of 7,900+

Probably Relevant

Analyzing Raptor Pharmaceutical Corp

Raptor Pharmaceutical Corp and La Jolla Pharmaceutical are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, earnings, analyst recommendations, dividends and profitability. Raptor Pharmaceutical Corp has higher revenue, but lower earnings than La Jolla Pharmaceutical.

Comparing La Jolla Pharmaceutical

La Jolla Pharmaceutical and Raptor Pharmaceutical Corp are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, institutional ownership, profitability, dividends, analyst recommendations and valuation. Raptor Pharmaceutical Corp has higher revenue, but lower earnings than La Jolla Pharmaceutical.

STA Pharmaceutical merges with WuXi’s pharmaceutical development division

STA Pharmaceutical, a subsidiary of China-based WuXi AppTec, has merged its operations with the parent company’s pharmaceutical development services (PDS) division.

Head-To-Head Survey: Raptor Pharmaceutical Corp (RPTP) vs. Its Competitors

Raptor Pharmaceutical Corp is one of 293 public companies in the "Bio Therapeutic Drugs" industry, but how does it weigh in compared to its competitors? We will compare Raptor Pharmaceutical Corp to similar businesses based on the strength of its dividends, valuation, risk, analyst recommendations, institutional ownership, earnings and profitability. Raptor Pharmaceutical Corp's competitors ha...

M&As this week: Sun Pharmaceutical Industries, Northeast Pharmaceutical Group, Mallinckrodt

Sun Pharmaceutical Industries has announced the acquisition of a 15.91% stake in Krystal Biotech for $7m.

M Pharmaceutical, Inc.: M Pharmaceutical USA Announces a Change of Name to Callitas Therapeutics

CINCINNATI, OH / ACCESSWIRE / August 1, 2017 / M Pharmaceutical Inc. (CSE: MQ, OTCQB: MPHMF, FWB: T3F2) ("M Pharma"), announces today that to better align with its expertise in the healthcare field...

BizVibe Announces Their List of the Top 10 Pharmaceutical Companies in Singapore

This innovation is driving profits, competition, and market growth: Singapore's pharmaceutical industry is estimated to be worth more than USD 800 million by 2020. In a recent article titled Top 10 Pharmaceutical Companies in Singapore , BizVibe identifies the top 10 players in Singapore's innovative and quickly-growing pharmaceutical industry.

Oasmia Pharmaceutical AB: Notification from Oasmia Pharmaceutical AB

Uppsala, Sweden, 2017-09-11 22:05 CEST (GLOBE NEWSWIRE) -- Oasmia Pharmaceutical AB (NASDAQ: OASM), a developer of a new generation of drugs within human and veterinary oncology, hereby issues a no...

Endo International acquires Par Pharmaceutical

Endo International and Par Pharmaceutical Holdings have entered into a definitive agreement under which Endo will acquire privately-held Par from TPG in a transaction valued at $8.05 billion, including assumption of Par debt. The combination will create a leading specialty pharmaceutical company with a generics business that is one of the industry's fastest growing and more » The post Endo Intern...

Pharmaceutical Development Group-Pharmaceutical Regulatory Consultant and FDA Regulatory Strategist

Pharmaceutical Development Group (PDG) provides pharmaceutical regulatory consulting to firms located around the world.

Partnership formed to combat pharmaceutical counterfeiting

Bio/pharmaceutical analytical and bioanalytical contract solutions provider, SGS, has entered into a partnership with Nature’s Fingerprint to combat pharmaceutical counterfeiting

Reviewing Teva Pharmaceutical Industries Limited (TEVA) & Its Competitors

Teva Pharmaceutical Industries Limited is one of 112 public companies in the "Pharmaceuticals" industry, but how does it weigh in compared to its competitors? We will compare Teva Pharmaceutical Industries Limited to related businesses based on the strength of its valuation, institutional ownership, earnings, dividends, analyst recommendations, profitability and risk. Teva Pharmaceutical Industrie...

Deals this week: North China Pharmaceutical, Arena Pharmaceuticals, Enterome Bioscience

Chinese pharmaceutical company North China Pharmaceutical has announced the completion of a public offering of ten million short-term bonds to raise CNY1bn ($146.93m).

Mallinckrodt to Acquire InfaCare Pharmaceutical

STAINES-UPON-THAMES, United Kingdom, Aug. 4, 2017 /PR Newswire/ — Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, and InfaCare Pharmaceutical Corporation today announced that they have entered into an agreement under which Mallinckrodt will acquire InfaCare, a privately held specialty pharmaceutical company focused on development and commercialization of prop...

Oasmia Pharmaceutical AB: Oasmia Pharmaceutical receives market approval for its Anti-Cancer Drug Doxophos® in Russia

Uppsala, Sweden, 2017-08-08 08:40 CEST (GLOBE NEWSWIRE) -- Oasmia Pharmaceutical AB (NASDAQ: OASM), a developer of a new generation of drugs within human and veterinary oncology, announced today th...

M&As this week: Northeast Pharmaceutical Group, Principia SGR, Commelina

Chinese pharmaceutical company Northeast Pharmaceutical Group plans to acquire 60% stake in a medicine company based in Dandong, China, through its subsidiary for CNY3.9m ($0.57m).

Aoxing Pharmaceutical Company, Inc.: Aoxing Pharmaceutical Announces Delisting and Deregistration of Common Stock

FOSTER CITY, CA / ACCESSWIRE / September 25, 2017 / Aoxing Pharmaceutical Company, Inc. (NYSE American: AXN) today announced that its board of directors has made a determination to remove the Aoxin...

Pharmaceutical Contract Sales Market - Industry Shares, Market Strategies and Key Players 2017 - 2025

Global Pharmaceutical Contract Sales Market: Snapshot Globally, many regional and international companies are taking help of pharmaceutical contract sales organizations to varying extents and the trend is likely to increase in the coming years. The global pharmaceutical industry, especially with the revival of the world economy from the great recession, is following a notable growth trajectory.

Oasmia Pharmaceutical AB: Change in the number of shares and votes in Oasmia Pharmaceutical AB (publ)

Uppsala, Sweden, 2017-07-31 22:05 CEST (GLOBE NEWSWIRE) -- Oasmia Pharmaceutical AB (publ) ("Oasmia" or "Company" or "Group") has, as has been previously announced, carried out a rights issue. Appr...

Merck, Pfizer collaborate with Corning on pharmaceutical glass packaging

Merck, Pfizer and Corning announced collaborations that have enabled the modernization of pharmaceutical packaging with the introduction of Corning Valor Glass. This revolutionary pharmaceutical glass packaging solution enhances the storage and delivery of today’s drug formulations and provides more reliable access to medicines essential to public health. Deep pharmaceutical formulation and ...

WuXi’s Pharmaceutical Development Services Division, STA merge

STA Pharmaceutical, a WuXi AppTec group company and an open-access capability and technology platform for small molecule pharmaceutical development and manufacturing—announces that it has merged with WuXi AppTec’s Pharmaceutical Development Services (PDS) division. The PDS division offers pre-formulation development, formulation development, as well as Clinical Trial Material (CTM) manufacturi...

M Pharmaceutical, Inc.: M Pharmaceutical Announces Name Change to Callitas Health Inc. and Share Consolidation

CINCINNATI, OH / ACCESSWIRE / September 15, 2017 / Callitas Health Inc., formerly M Pharmaceutical Inc. (CSE: MQ)(CSE: LILY, OTCQB: MPHMF, FWB: T3F2) ("Callitas" or the "Company"), announces today ...

View Press Release

The global pharmaceutical filtration market is expected to grow at a CAGR of more than 11 % during the forecast period. The increasing prevalence of heart attacks and diabetes has increased the demand for pharmaceutical products such as antibodies, hormones, and vaccines, which further increase the adoption of pharmaceutical filtration, thereby increasing their demand.

M&As this week: Zhejiang Hisoar Pharmaceutical, tella

Chinese pharmaceutical company Zhejiang Hisoar Pharmaceutical plans to divest a 16.1% stake in a biotechnology company.

Active Pharmaceutical Ingredients/API Industry by Type...

PUNE, MAHARASHTRA, INDIA, June 19, 2017 / / -- Active Pharmaceutical Ingredient is the integral part of the drug because of which the disease gets cured. The global active pharmaceutical ingredient industry is now experience of rapid change.

Quick Search

News Quicklinks